Predictive Oncology Total Assets 2010-2023 | POAI
Predictive Oncology total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Predictive Oncology Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $14 |
| 2022 | $26 |
| 2021 | $44 |
| 2020 | $13 |
| 2019 | $22 |
| 2018 | $4 |
| 2017 | $4 |
| 2016 | $3 |
| 2015 | $6 |
| 2014 | $1 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Predictive Oncology Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $14 |
| 2023-09-30 | $18 |
| 2023-06-30 | $21 |
| 2023-03-31 | $25 |
| 2022-12-31 | $26 |
| 2022-09-30 | $33 |
| 2022-06-30 | $36 |
| 2022-03-31 | $40 |
| 2021-12-31 | $44 |
| 2021-09-30 | $51 |
| 2021-06-30 | $57 |
| 2021-03-31 | $40 |
| 2020-12-31 | $13 |
| 2020-09-30 | $25 |
| 2020-06-30 | $27 |
| 2020-03-31 | $25 |
| 2019-12-31 | $22 |
| 2019-09-30 | $32 |
| 2019-06-30 | $32 |
| 2019-03-31 | $5 |
| 2018-12-31 | $4 |
| 2018-09-30 | $5 |
| 2018-06-30 | $4 |
| 2018-03-31 | $6 |
| 2017-12-31 | $4 |
| 2017-09-30 | $3 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $3 |
| 2016-09-30 | $2 |
| 2016-06-30 | $3 |
| 2016-03-31 | $4 |
| 2015-12-31 | $6 |
| 2015-09-30 | $8 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $0 |
| 2013-03-31 | $1 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.005B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.573B | 22.01 |
| Inspire Medical Systems (INSP) | United States | $7.095B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.623B | 0.00 |
| Axonics (AXNX) | United States | $3.399B | 0.00 |
| 10x Genomics (TXG) | United States | $3.279B | 0.00 |
| Enovis (ENOV) | United States | $3.080B | 23.40 |
| Azenta (AZTA) | United States | $2.905B | 236.77 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.789B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.644B | 0.00 |
| Privia Health (PRVA) | United States | $2.156B | 95.63 |
| Schrodinger (SDGR) | United States | $1.738B | 0.00 |
| Omnicell (OMCL) | United States | $1.260B | 30.82 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.854B | 0.00 |
| Standard BioTools (LAB) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.330B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.322B | 0.00 |
| Pulmonx (LUNG) | United States | $0.290B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.132B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.95 |
| 111 (YI) | China | $0.088B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |